Baseline Characteristics of Patients with Heart Failure with Preserved Ejection Fraction in the EMPEROR-Preserved Trial
Stefan D. Anker(German Centre for Cardiovascular Research), Milton Packer(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Michael Böhm(Saarland University), Dragoş Vinereanu(Carol Davila University of Medicine and Pharmacy), Dong‐Ju Choi(Inserm), Martina Brueckmann, Piotr Ponikowski(Wroclaw Medical University), Javed Butler(University of Mississippi Medical Center), Gerasimos Filippatos(National and Kapodistrian University of Athens), Eduardo Chuquiure‐Valenzuela(Inserm), Stuart Pocock(University of London), Sergio V. Perrone(Inserm), Sven Schnaidt(Inserm), Stefano Taddei(University of Pisa), Faı̈ez Zannad(Inserm), Marie‐France Seronde(Centre Hospitalier Universitaire de Besançon), James L. Januzzi(Harvard University), Ileana L. Piña(Inserm), José Ramón González‐Juanatey(Universidade de Santiago de Compostela), Muhammad Shahzeb Khan(University of Mississippi Medical Center), Stephen J. Nicholls(Australian Centre for Heart Health), Edimar Alcides Bocchi(Universidade de São Paulo), Hans‐Peter Brunner‐La Rocca(Inserm), Michele Senni(Inserm), Stefan Janssens(Inserm), Juan Esteban Gómez‐Mesa(Inserm), Janet Schnee(Boehringer Ingelheim (United States)), Iain Squire(University of Leicester), Nadia Giannetti(Inserm), Vijay Chopra(Medanta The Medicity), Subodh Verma(University of Toronto), Béla Merkely(Semmelweis University), Hiroyuki Tsutsui(Kyushu University), Jian Zhang(Texas A&M Health Science Center), João Pedro Ferreira(Inserm), Jindřich Špinar(University Hospital Brno), David Sim(Inserm), Waheed Jamal(Inserm)
Cited by 135
Related Papers
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
|European Journal of Heart Failure|2016|5.9k